US4777964A
(en)
|
1986-01-02 |
1988-10-18 |
David Briggs |
System for obtaining blood samples and submitting for testing of aids
|
US5096830A
(en)
|
1987-11-17 |
1992-03-17 |
Adeza Biomedical Corporation |
Preterm labor and membrane rupture test
|
US5223440A
(en)
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
US5281522A
(en)
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
US4919889A
(en)
|
1988-09-15 |
1990-04-24 |
Aspen Diagnostics Corporation |
Sample collection and transport fluid composition
|
DE69231636T2
(de)
|
1991-11-04 |
2001-05-23 |
Adeza Biomedical Corp |
Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko
|
WO1993009432A1
(fr)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Procede de depistage pour l'identifaction de femmes presentant un risque accru d'accouchement imminent
|
US5516702A
(en)
|
1991-11-06 |
1996-05-14 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
CA2133967A1
(fr)
|
1993-02-24 |
1994-09-01 |
Spencer H. Lin |
Immobilisation de reactifs specifiques pour les tests de liaison
|
US5898005A
(en)
|
1993-02-24 |
1999-04-27 |
Dade Behring Inc. |
Rapid detection of analytes with receptors immobilized on soluble submicron particles
|
JP3441076B2
(ja)
|
1993-03-23 |
2003-08-25 |
ボロテリアク,ビクター |
妊娠哺乳類の羊膜破壊の検出法
|
US5431171A
(en)
|
1993-06-25 |
1995-07-11 |
The Regents Of The University Of California |
Monitoring fetal characteristics by radiotelemetric transmission
|
CA2170873A1
(fr)
|
1993-09-03 |
1995-03-09 |
Dariush Davalian |
Immuno-essais utilisant la fluorescence de l'oxygene
|
US5650394A
(en)
|
1993-11-04 |
1997-07-22 |
Adeza Biomedical |
Use of urinastatin-like compounds to prevent premature delivery
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
US5641636A
(en)
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
US6140099A
(en)
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
JP3064015B2
(ja)
|
1995-01-26 |
2000-07-12 |
メルク フロスト カナダ アンド カンパニー |
プロスタグランジンレセプターdp
|
EP0913405B1
(fr)
|
1995-10-31 |
2006-01-04 |
Maruha Corporation |
Anticorps monoclonal specifique de la prostaglandine d synthetase
|
US6678669B2
(en)
|
1996-02-09 |
2004-01-13 |
Adeza Biomedical Corporation |
Method for selecting medical and biochemical diagnostic tests using neural network-related applications
|
US6544193B2
(en)
|
1996-09-04 |
2003-04-08 |
Marcio Marc Abreu |
Noninvasive measurement of chemical substances
|
US6120460A
(en)
|
1996-09-04 |
2000-09-19 |
Abreu; Marcio Marc |
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
|
FI963989A
(fi)
|
1996-10-04 |
1998-04-05 |
Wallac Oy |
Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
|
WO1998040747A1
(fr)
|
1997-03-07 |
1998-09-17 |
Mount Sinai Hospital Corporation |
Methodes de diagnostic d'une regulation necessaire de l'invasion trophoblastique
|
US6875567B1
(en)
|
1997-11-10 |
2005-04-05 |
Genentech, Inc. |
Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis
|
US6610480B1
(en)
|
1997-11-10 |
2003-08-26 |
Genentech, Inc. |
Treatment and diagnosis of cardiac hypertrophy
|
US20020031513A1
(en)
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
US6267722B1
(en)
|
1998-02-03 |
2001-07-31 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
US6394952B1
(en)
|
1998-02-03 |
2002-05-28 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
US6506789B2
(en)
|
1998-06-03 |
2003-01-14 |
Shionogi & Co., Ltd. |
Methods for the treatment of itching comprising administering PGD2 receptor antagonist
|
US6149590A
(en)
|
1998-07-22 |
2000-11-21 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
US6126597A
(en)
|
1998-07-22 |
2000-10-03 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
US20010025140A1
(en)
|
1998-07-22 |
2001-09-27 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
US7109044B1
(en)
|
1998-09-04 |
2006-09-19 |
Maruha Corporation |
Method of detection and disease state management for renal diseases
|
ID29352A
(id)
|
1998-10-29 |
2001-08-23 |
Univ Texas |
Penggunaan turunan tiazolidindion untuk mencegah kontraksi uterin dalam persalinan prematur atau laktasi
|
JP2000249709A
(ja)
|
1999-02-26 |
2000-09-14 |
Maruha Corp |
冠血管インターベンション施行後の再狭窄の予測方法
|
US6126616A
(en)
|
1999-06-21 |
2000-10-03 |
Sanyal; Mrinal K. |
Collection of biological products from human accessory reproductive organs by absorbent systems
|
WO2001014882A1
(fr)
|
1999-08-23 |
2001-03-01 |
Bml, Inc. |
Identification des proprietes d'une substance pour les recepteurs de prostaglandine d
|
FR2809182B1
(fr)
|
2000-05-18 |
2003-08-15 |
Univ Rene Descartes |
Detection de l'il-6 pour la prevision des risques d'accouchement premature
|
US20010053876A1
(en)
|
2000-06-15 |
2001-12-20 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
US7314727B2
(en)
|
2000-07-21 |
2008-01-01 |
Maruha Corporation |
Methods to facilitate diagnosis of normal pressure hydrocephalus
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
AU2001288410A1
(en)
|
2000-08-28 |
2002-03-13 |
Patrick G. Morand |
Use of blood and plasma donor samples and data in the drug discovery process
|
US7217725B2
(en)
|
2000-09-14 |
2007-05-15 |
Allergan, Inc. |
Prostaglandin D2 antagonist
|
AU2002214015A1
(en)
|
2000-10-16 |
2002-04-29 |
Bayer Aktiengesellschaft |
Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
|
US7635571B2
(en)
|
2000-12-07 |
2009-12-22 |
Siemens Healthcare Diagnostics Products Gmbh |
Amplified signal in binding assays
|
AU2002302248B2
(en)
|
2001-05-23 |
2008-03-06 |
Merck Frosst Canada Ltd. |
Dihydropyrrolo[1,2-A]indole and tetrahydropyrido[1,2-A]-indole derivatives as prostaglandin D2 receptor antagonists
|
WO2003008978A2
(fr)
|
2001-07-18 |
2003-01-30 |
Merck Frosst Canada & Co. |
Dosages des recepteurs d2 eosinophiles de la prostaglandine
|
US20040197834A1
(en)
|
2001-07-20 |
2004-10-07 |
Francois Gervais |
Method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
|
US20050101841A9
(en)
|
2001-12-04 |
2005-05-12 |
Kimberly-Clark Worldwide, Inc. |
Healthcare networks with biosensors
|
CA2491094A1
(fr)
|
2002-07-01 |
2004-01-08 |
Univesity Of Rochester Medical Center |
Methode de determination de la probabilite de risque d'accouchement premature chez la femme enceinte
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
CN1777443B
(zh)
|
2002-07-19 |
2010-06-23 |
貝丝以色列女执事医疗中心 |
诊断和治疗先兆子痫或子痫的方法
|
DE60332248D1
(de)
|
2002-08-13 |
2010-06-02 |
N Dia Inc |
Vorrichtungen und verfahren zum nachweis von fruchtwasser in vaginalsekreten
|
DE60334462D1
(de)
|
2002-08-29 |
2010-11-18 |
Diagnostic Technologies Ltd |
En
|
JPWO2004030674A1
(ja)
|
2002-09-30 |
2006-01-26 |
塩野義製薬株式会社 |
プロスタグランジンd▲下2▼、プロスタグランジンd▲下2▼アゴニストおよびプロスタグランジンd▲下2▼アンタゴニストの新規用途
|
AU2003284166A1
(en)
|
2002-10-23 |
2004-05-13 |
University Of Hawaii |
Methods for diagnosing and treating pre-term labor
|
US20040100376A1
(en)
|
2002-11-26 |
2004-05-27 |
Kimberly-Clark Worldwide, Inc. |
Healthcare monitoring system
|
WO2004072638A1
(fr)
|
2003-02-05 |
2004-08-26 |
Ciphergen Biosystems, Inc. |
Evaluation non invasive du milieu intra-amniotique
|
EP1590668A2
(fr)
|
2003-02-06 |
2005-11-02 |
Adeza Biomedical Corporation |
Procedes de criblage et de traitement pour le prevention de l'accouchement premature
|
US7191068B2
(en)
|
2003-03-25 |
2007-03-13 |
Proteogenix, Inc. |
Proteomic analysis of biological fluids
|
US8068990B2
(en)
|
2003-03-25 |
2011-11-29 |
Hologic, Inc. |
Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
|
US20040203079A1
(en)
|
2003-04-09 |
2004-10-14 |
Research Foundation Of The State University Of New York |
Methods and kits for detecting cerebrospinal fluid in a sample
|
US8003765B2
(en)
|
2003-04-09 |
2011-08-23 |
Stony Brook Anaesthesiology, University Faculty Practice Corporation |
Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
|
US20070003992A1
(en)
|
2003-04-09 |
2007-01-04 |
Pentyala Srinivas N |
Methods and kits for detecting cerebrospinal fluid in a sample
|
EP1620006A4
(fr)
|
2003-05-02 |
2009-12-02 |
Univ Johns Hopkins |
Dispositifs, systemes et procedes de mesure de bioimpedance de tissu cervical et procedes pour diagnostiquer et traiter un col de l'uterus humain
|
CN1791577A
(zh)
|
2003-05-20 |
2006-06-21 |
麦克弗罗斯特加拿大有限公司 |
氟-甲基磺酰取代的环烷并吲哚和它们作为前列腺素d2拮抗剂的用途
|
WO2005007223A2
(fr)
|
2003-07-16 |
2005-01-27 |
Sasha John |
Systemes et procedes d'administration programmable de medicaments pour l'administration de fluides et de concentrations multiples
|
JP3897117B2
(ja)
|
2003-09-24 |
2007-03-22 |
マルハ株式会社 |
妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
|
JP4354954B2
(ja)
|
2003-09-26 |
2009-10-28 |
株式会社マルハニチロ水産 |
関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
|
US20050131287A1
(en)
|
2003-12-16 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Detection of premature rupture of the amniotic membrane
|
US20060024725A1
(en)
|
2004-07-30 |
2006-02-02 |
Robert Hussa |
Oncofetal fibronectin as a marker for pregnancy-related indications
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
US20080254479A1
(en)
|
2004-08-30 |
2008-10-16 |
Cervimark, Llc |
Methods and Kits For Predicting Risk For Preterm Labor
|
SG155257A1
(en)
|
2004-09-24 |
2009-09-30 |
Beth Israel Hospital |
Methods of diagnosing and treating complications of pregnancy
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
HN2005000795A
(es)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
JP5009811B2
(ja)
|
2004-12-21 |
2012-08-22 |
イェール ユニバーシティ |
子癇前症の検出
|
CA2528531A1
(fr)
|
2005-01-06 |
2006-07-06 |
Mount Sinai Hospital |
Indicateurs d'accouchement premature
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
US20060257901A1
(en)
*
|
2005-03-24 |
2006-11-16 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
US20070128589A1
(en)
|
2005-07-13 |
2007-06-07 |
Sanders Mitchell C |
Substrates, sensors, and methods for assessing conditions in females
|
JP5064219B2
(ja)
|
2005-07-22 |
2012-10-31 |
塩野義製薬株式会社 |
Pgd2受容体アンタゴニスト活性を有するアザインドール酸誘導体
|
CN101309929A
(zh)
|
2005-09-15 |
2008-11-19 |
创源生物科技(武汉)有限公司 |
胎膜早破的一个标志物
|
GT200600457A
(es)
|
2005-10-13 |
2007-04-27 |
Aventis Pharma Inc |
Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
|
US8076315B2
(en)
|
2005-10-14 |
2011-12-13 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
US20070111326A1
(en)
|
2005-11-14 |
2007-05-17 |
Abbott Laboratories |
Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
|
US20080009552A1
(en)
|
2006-03-23 |
2008-01-10 |
Craig Pennell |
Markers of pre-term labor
|
AR060403A1
(es)
|
2006-04-12 |
2008-06-11 |
Sanofi Aventis |
Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
|
SI2037967T1
(sl)
|
2006-06-16 |
2017-04-26 |
The Trustees Of The University Of Pennsylvania |
Antagonisti receptorja za prostaglandin d2 za zdravljenje androgene alopecije
|
AU2007276885A1
(en)
|
2006-07-25 |
2008-01-31 |
Sanofi-Aventis |
2-phenyl-indoles as prostaglandin D2 receptor antagonists
|
WO2008039941A2
(fr)
|
2006-09-27 |
2008-04-03 |
The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services |
Protéine scgb3a2 utilisée en tant que facteur de croissance et qu'agent anti-apoptotique
|
ES2647472T3
(es)
|
2006-10-03 |
2017-12-21 |
Genzyme Corporation |
Anticuerpos contra TGF-BETA para uso en el tratamiento de lactantes con riesgo de desarrollar displasia broncopulmonar
|
WO2008073491A1
(fr)
|
2006-12-11 |
2008-06-19 |
University Of Florida Research Foundation, Inc. |
Système et procédé permettant d'analyser l'évolution du travail et du travail préterme pendant l'accouchement
|
EP2129660A2
(fr)
|
2006-12-19 |
2009-12-09 |
Pfizer Products Inc. |
Dérivés de nicotinamide en tant qu'inhibiteurs de h-pgds et leur utilisation pour le traitement de maladies liées aux prostaglandines d2
|
AU2007338634A1
(en)
|
2006-12-26 |
2008-07-03 |
Brigham Young University |
Serum proteomics system and associated methods
|
EP2132196A1
(fr)
|
2007-02-26 |
2009-12-16 |
Pfizer Products Inc. |
Composés hétérocycliques utiles dans le traitement de maladies et de conditions
|
US20090058072A1
(en)
|
2007-08-30 |
2009-03-05 |
Shirlee Ann Weber |
Record sheets with integrated themes
|
US20100251394A1
(en)
|
2007-09-20 |
2010-09-30 |
The Johns Hopkins University |
Treatment and prevention of ischemic brain injury
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
WO2009059259A2
(fr)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Détection de l'aggravation d'une pathologie rénale chez des sujets atteints de lupus érythémateux disséminé
|
US20100298368A1
(en)
|
2007-11-06 |
2010-11-25 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
US20130177485A1
(en)
|
2007-11-27 |
2013-07-11 |
Momtec Life Ltd. Of Yazmot Haemek |
Diagnostic device for identifying rupture of membrane during pregnancy
|
US20110065139A1
(en)
|
2007-11-27 |
2011-03-17 |
Jacob Mullerad |
diagnostic device for identifying rupture of membrane during pregnancy
|
EP2229358B1
(fr)
|
2007-12-14 |
2011-03-23 |
Pulmagen Therapeutics (Asthma) Limited |
Indoles et leur utilisation thérapeutique
|
CA2711071A1
(fr)
|
2008-01-07 |
2009-07-16 |
Ortho-Clinical Diagnostics, Inc. |
Determination d'un complexe sflt-1 : facteur angiogenique
|
JP2011509985A
(ja)
|
2008-01-18 |
2011-03-31 |
プルマジェン セラピューティクス (アズマ) リミテッド |
Crth2受容体に対して活性なインドール
|
CN102216468B
(zh)
|
2008-01-25 |
2014-06-11 |
珀金埃尔默健康科学股份有限公司 |
确定产前并发症风险的方法
|
WO2009097584A1
(fr)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Biomarqueurs de sérum maternel pour la détection de pré-éclampsie
|
WO2009097579A1
(fr)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Changements protéomiques dépendant de l'age gestationnel de sérum maternel destinés à surveiller la santé de la mère et du foetus
|
GB2460597B8
(en)
|
2008-02-01 |
2014-03-12 |
Amira Pharmaceuticals Inc |
N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
|
ES2566739T3
(es)
|
2008-02-01 |
2016-04-15 |
Brickell Biotech, Inc. |
Aminoalquilbifenilo N,N-disustituidos antagonistas de receptores de prostaglandina D2
|
WO2009102893A2
(fr)
|
2008-02-14 |
2009-08-20 |
Amira Pharmaceuticals, Inc. |
Composés diaryliques cycliques en tant qu'antagonistes de récepteurs de prostaglandine d2
|
EP2245022A4
(fr)
|
2008-02-25 |
2012-02-22 |
Panmira Pharmaceuticals Llc |
Antagonistes des récepteurs d2 de la prostaglandine
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
EP2288367B1
(fr)
|
2008-05-16 |
2015-10-07 |
Corthera, Inc. |
Relaxine H2 pour son utilisation dans le traitement de la dilatation prématurée du col utérin
|
EP2300425A4
(fr)
|
2008-06-24 |
2012-03-21 |
Panmira Pharmaceuticals Llc |
Antagonistes de cycloalcaneýb¨indole de récepteurs de prostaglandine d2
|
KR101325367B1
(ko)
|
2008-07-03 |
2013-11-11 |
판미라 파마슈티칼스, 엘엘씨 |
프로스타글란딘 d2 수용체의 길항제
|
FR2934681B1
(fr)
|
2008-07-29 |
2011-09-30 |
Bastien Karkouche |
Dispositif pour la capture de particules biologiques et utilisation.
|
US20100029006A1
(en)
|
2008-08-04 |
2010-02-04 |
Rosenblatt Kevin P |
Multiplexed diagnostic test for preterm labor
|
PE20110843A1
(es)
|
2008-09-22 |
2011-12-08 |
Cayman Chem Co |
Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica
|
GB2463788B
(en)
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
US8378107B2
(en)
|
2008-10-01 |
2013-02-19 |
Panmira Pharmaceuticals, Llc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
WO2010042652A2
(fr)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Antagonistes hétéroalkyl biphényle des récepteurs de la prostaglandine d2
|
GB2465062B
(en)
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
US9180114B2
(en)
|
2008-11-26 |
2015-11-10 |
President And Fellows Of Harvard College |
Neurodegenerative diseases and methods of modeling
|
WO2010085820A2
(fr)
|
2009-01-26 |
2010-07-29 |
Amira Pharmaceuticals, Inc. |
Composés tricycliques en tant qu'antagonistes des récepteurs d2 de la prostaglandine
|
US20120046261A1
(en)
|
2009-02-27 |
2012-02-23 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing and preventing spontaneous preterm birth
|
GB0905964D0
(en)
|
2009-04-06 |
2009-05-20 |
King S College London |
Marker
|
WO2011017201A2
(fr)
|
2009-08-05 |
2011-02-10 |
Amira Pharmaceuticals, Inc. |
Antagoniste de dp2 et ses utilisations
|
US20110090048A1
(en)
|
2009-09-29 |
2011-04-21 |
Li Conan K |
Data Transmission Device with User Identification Capability
|
AU2010313447A1
(en)
|
2009-10-29 |
2012-05-31 |
The Trustees Of The University Of Pennsylvania |
Method of predicting risk of preterm birth
|
CA2778838A1
(fr)
|
2009-11-12 |
2011-05-19 |
Cervilenz Inc. |
Dispositifs et procedes pour la mesure du col
|
AU2010325147B2
(en)
|
2009-11-25 |
2016-06-30 |
Hologic, Inc. |
Detection of intraamniotic infection
|
CA2807050C
(fr)
|
2009-12-08 |
2019-06-18 |
Ozlem Equils |
Bio-marqueur de diagnostic pour identifier des femmes qui presentent un risque d'accouchement avant terme
|
WO2011103473A2
(fr)
|
2010-02-18 |
2011-08-25 |
The Johns Hopkins University |
Dispositif de surveillance d'accouchement prématuré
|
AU2011227417A1
(en)
|
2010-03-16 |
2012-10-11 |
Aventis Pharmaceuticals Inc. |
Substituted pyrimidines as prostaglandin D2 receptor antagonists
|
TW201204708A
(en)
|
2010-03-16 |
2012-02-01 |
Aventis Pharma Inc |
A substituted pyrimidine as a prostaglandin D2 receptor antagonist
|
CN102791689B
(zh)
|
2010-03-22 |
2014-10-29 |
埃科特莱茵药品有限公司 |
3-(杂芳基-氨基)-1,2,3,4-四氢-9h-咔唑衍生物及其作为前列腺素d2受体调节剂的用途
|
WO2011119757A2
(fr)
|
2010-03-23 |
2011-09-29 |
The Reproductive Research Technologies, Lp |
Mesure non invasive de la propagation associée à l'électromyographie utérine et de la fréquence du spectre de puissance permettant de prédire une menace réelle de travail et d'accouchement prématurés
|
WO2011128357A2
(fr)
*
|
2010-04-13 |
2011-10-20 |
Pronota N.V. |
Biomarqueurs de troubles liés à l'hypertension pendant la grossesse
|
EP2706041B1
(fr)
*
|
2010-05-14 |
2018-10-03 |
Beth Israel Deaconess Medical Center |
Dispositifs extracorporels et procédés de traitement des complications de la grossesse
|
US20110312928A1
(en)
|
2010-06-18 |
2011-12-22 |
Lipocine Inc. |
Progesterone Containing Oral Dosage Forms and Related Methods
|
US20110312927A1
(en)
|
2010-06-18 |
2011-12-22 |
Satish Kumar Nachaegari |
Progesterone Containing Oral Dosage Forms and Related Methods
|
WO2011163554A2
(fr)
|
2010-06-25 |
2011-12-29 |
Winthrop-University Hospital |
Prostaglandine d2 synthase de type lipocaline comme biomarqueur pour la progression et le pronostic du cancer du poumon
|
CA2805452C
(fr)
|
2010-07-05 |
2018-07-31 |
Actelion Pharmaceuticals Ltd |
Derives d'heterocyclyle substitues par un 1-phenyle et leur utilisation en tant que modulateurs des recepteurs de la prostaglandine d2
|
AP2013006667A0
(en)
|
2010-07-12 |
2013-01-31 |
Therasyn Sensors Inc |
A device and methods for in vivo monitoring of an individual
|
US8765487B2
(en)
|
2010-09-01 |
2014-07-01 |
Clinical Innovations |
Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
|
KR101888213B1
(ko)
|
2010-10-01 |
2018-08-13 |
홀로직, 인크. |
진단 시스템에 사용하기 위한 면역분석 시험 스트립
|
US10669569B2
(en)
|
2010-10-15 |
2020-06-02 |
Navinci Diagnostics Ab |
Dynamic range methods
|
WO2012076553A2
(fr)
|
2010-12-06 |
2012-06-14 |
Pronota N.V. |
Biomarqueurs et paramètres des troubles d'hypertension de la grossesse
|
GB201101621D0
(en)
|
2011-01-31 |
2011-03-16 |
Olink Ab |
Method and product
|
US20120196285A1
(en)
|
2011-01-31 |
2012-08-02 |
Esoterix Genetic Laboratories, Llc |
Methods for Enriching Microparticles or Nucleic Acids Using Binding Molecules
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
ES2650263T3
(es)
*
|
2011-11-09 |
2018-01-17 |
F. Hoffmann-La Roche Ag |
Dinámica de la razón de SFLT-1 o endoglina/PLGF como indicador para preeclampsia inminente y/o síndrome de HELLP
|
AU2013218753A1
(en)
|
2012-02-06 |
2014-09-25 |
Perkinelmer Biosignal, Inc. |
Dual-acceptor time-resolved-fret
|
US20150099655A1
(en)
|
2012-05-08 |
2015-04-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and Compositions for Providing a Preeclampsia Assessment
|
SG11201407667UA
(en)
|
2012-06-27 |
2015-02-27 |
Hoffmann La Roche |
MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
|
WO2014036440A2
(fr)
|
2012-08-30 |
2014-03-06 |
Ansh Labs Llc |
Papp-a2 en tant que marqueur pour la surveillance, la prédiction et le diagnostic de la prééclampsie
|
US9797903B2
(en)
|
2012-10-24 |
2017-10-24 |
Winthrop-University Hospital |
Non-invasive biomarker to identify subject at risk of preterm delivery
|
US20150330989A1
(en)
*
|
2012-11-15 |
2015-11-19 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
CA2903929A1
(fr)
*
|
2013-03-04 |
2014-09-12 |
Iq Products B.V. |
Marqueur pronostique pour determiner le risque de preeclampsie precoce
|
EP3077825B1
(fr)
|
2013-12-03 |
2020-11-25 |
Cézanne S.A.S. |
Procédé de détermination sélective de facteur de croissance placentaire de 2
|
ES2685831T3
(es)
|
2014-01-24 |
2018-10-11 |
F. Hoffmann-La Roche Ag |
Predicción del síndrome de HELLP postparto, de la eclampsia postparto, o de la preeclampsia postparto
|
US10281475B2
(en)
|
2014-03-27 |
2019-05-07 |
Wayne State University |
Systems and methods to identify and treat subjects at risk for obstetrical complications
|
WO2016019176A1
(fr)
|
2014-07-30 |
2016-02-04 |
Matthew Cooper |
Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie.
|
CN107636466B
(zh)
|
2015-02-18 |
2020-07-21 |
阿斯顿大学 |
先兆子痫的诊断性测定和治疗
|
WO2016134324A1
(fr)
|
2015-02-20 |
2016-08-25 |
Neoteryx, Llc |
Méthode et appareil d'acquisition de sang pour analyse
|
US20180114600A1
(en)
|
2015-03-23 |
2018-04-26 |
Adelaide Research & Innovation Pty Ltd |
Methods and systems for determining risk of a pregnancy complication occurring
|
JP2018536170A
(ja)
|
2015-09-11 |
2018-12-06 |
ウニベルシダッド デ ロス アンデス |
妊娠関連疾患を同定するin vitro方法
|
NL2016967B1
(en)
|
2016-06-15 |
2017-12-21 |
Iq Products B V |
Markers and their ratio to determine the risk for early-onset preeclampsia.
|
US20190353667A1
(en)
|
2017-02-06 |
2019-11-21 |
Astute Medical, Inc. |
Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
|
US20190079097A1
(en)
|
2017-09-13 |
2019-03-14 |
Progenity, Inc. |
Preeclampsia biomarkers and related systems and methods
|
JP2020533595A
(ja)
|
2017-09-13 |
2020-11-19 |
プロジェニティ, インコーポレイテッド |
子癇前症バイオマーカならびに関連するシステムおよび方法
|